The Optimal Imaging Window for Dysplastic Colorectal Polyp Detection Using c-Met-Targeted Fluorescence Molecular Endoscopy

Conclusion: FME using EMI-137 appeared to be safe and feasible within a 1- to 3-h dose-to-imaging interval. No clinically significant differences were observed among the cohorts, although a 1-h dose-to-imaging interval was preferred from a clinical perspective. Future studies will investigate EMI-137 for improved colorectal polyp detection during screening colonoscopies.

Source: Journal of Nuclear Medicine - September 30, 2020 Category: Nuclear Medicine Authors: de Jongh, S. J., Vrouwe, J. P. M., Voskuil, F. J., Schmidt, I., Westerhof, J., Koornstra, J. J., de Kam, M. L., Karrenbeld, A., Hardwick, J. C. H., Robinson, D. J., Burggraaf, J., Kamerling, I. M. C., Nagengast, W. B. Tags: Clinical Source Type: research